Provider review
Obu Health review
Four products, four prices, all readable before you answer anything.
Both GLP-1 figures are floors with no ceiling and no dose, which leaves the structure underneath unknowable.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Obu Health
$190/mo sema · $239/mo tirz
- Vs median
- $21/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The catalog is the whole design here: four products, four prices, all visible before you scroll or answer anything, which is more than a good part of this category manages. The two GLP-1 figures sit mid-range with a fifty-dollar gap between them, which is roughly what the difference in compounding cost would predict and therefore reads as a real price rather than a marketing one. If you are comparing sellers on the entry rate this is a straightforward row with nothing hidden behind it — the assessment is free, the physician review is described, and nothing on the page suggests a membership or a separate dispensing charge. The gap is the one that keeps recurring: both figures are floors, no milligram is published, and there is no statement about what happens to the bill as a dose climbs. That matters more than usual on a starting-from price, because a floor with no ceiling and no dose is compatible with almost any structure underneath it — flat pricing, per-dose pricing, or a ladder that steepens. One small detail is worth noticing: one product's figure carries no billing period while the three around it do, which is the kind of inconsistency that makes a catalog harder to trust than the individual numbers in it deserve.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want every price visible before you answer a single question
- You want a mid-range figure per molecule with no membership implied underneath
- You want longevity products from the same prescriber as the weight-loss line
Look elsewhere if
- You need to know what happens above the entry price. Nothing published says
- You want a dose behind the figure. Neither one carries one
- You want the compounding pharmacy named. It is not, anywhere on the site
What it actually costs
Price as published
Compounded semaglutide from $190/mo and compounded tirzepatide from $239/mo, both printed on the homepage above the fold before any intake, alongside NAD+ from $219 and sermorelin from $149/mo · the gap between the two GLP-1 figures is $49, which is close to the middle of the usual spread · treatment is described as physician-reviewed following an online assessment, with medication shipped directly and ongoing support · both figures are "starting from" and no dose sits behind either, so neither can be attached to a quantity of drug and nothing says whether the price holds as the dose rises · the NAD+ line carries no period on its figure at all, unlike the three beside it, so that one is not a monthly rate on the page's own evidence · no compounding pharmacy is named
- Vs median
- $21/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. Four products with four prices, all readable above the fold before any assessment, and the gap between the two molecules is close to what the difference in compounding cost would predict — which makes it read as a real price rather than a marketing one. Both GLP-1 figures are floors with no ceiling and no dose behind them, and a floor with neither is compatible with almost any structure underneath: flat pricing, per-dose pricing, or a ladder that steepens. No compounding pharmacy is named, and one product on the same catalog carries no billing period while the three beside it do.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Four products with four prices, all readable before any assessment.
- The gap between the two molecules is close to what the compounding cost difference predicts.
- Physician review after an online assessment is described, with shipping and support included.
Pharmacy, labs and oversight
Obu Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Obu Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The catalog is the whole design here: four products, four prices, all visible before a reader scrolls or answers anything, which is more than a good part of this category manages. The two GLP-1 figures sit mid-range with a fifty-dollar gap between them, which is roughly what the difference in compounding cost would predict and therefore reads as a real price rather than a marketing one. For a reader comparing sellers on the entry rate this is a straightforward row with nothing hidden behind it — the assessment is free, the physician review is described, and nothing on the page suggests a membership or a separate dispensing charge. The gap is the one this site keeps finding: both figures are floors, no milligram is published, and there is no statement about what happens to the bill as a dose climbs. That matters more than usual on a starting-from price, because a floor with no ceiling and no dose is compatible with almost any structure underneath it — flat pricing, per-dose pricing, or a ladder that steepens. One small detail on the page is worth noticing as a reader: the NAD+ product's figure carries no billing period while the three around it do, which is the kind of inconsistency that makes a catalog harder to trust than the individual numbers in it deserve.
The honest cons
Both GLP-1 figures are floors with no ceiling and no dose behind them.
- Nothing states whether either price holds as the dose is increased.
- No compounding pharmacy is named anywhere on the site.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Obu Health is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#245 of 373
Ordered with the companies that pay us first, and Obu Health is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.